Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
2.180
+0.100 (4.81%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $7.96 million as of October 29, 2024. Its market cap has increased by 7.59% in one year.
Market Cap
7.96M
Enterprise Value
-4.39M
1-Year Change
7.59%
Ranking
Category
Stock Price
$2.18
Market Cap Chart
Since March 21, 2014, Pulmatrix's market cap has decreased from $30.40M to $7.96M, a decrease of -73.81%. That is a compound annual growth rate of -11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 7.60M | 11.76% |
| Dec 29, 2023 | 6.80M | -51.77% |
| Dec 30, 2022 | 14.10M | -42.68% |
| Dec 31, 2021 | 24.60M | -39.85% |
| Dec 31, 2020 | 40.90M | 137.79% |
| Dec 31, 2019 | 17.20M | 52.21% |
| Dec 31, 2018 | 11.30M | -61.95% |
| Dec 29, 2017 | 29.70M | 241.38% |
| Dec 30, 2016 | 8.70M | -85.74% |
| Dec 31, 2015 | 61.00M | 263.10% |
| Dec 31, 2014 | 16.80M | -44.74% |
| Mar 21, 2014 | 30.40M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhongchao | 8.03M |
| Cyclerion Therapeutics | 7.95M |
| Plus Therapeutics | 7.93M |
| Galecto | 7.88M |
| NLS Pharmaceutics AG | 7.80M |
| Universe Pharmaceuticals INC | 7.46M |
| Moleculin Biotech | 7.45M |
| GT Biopharma | 7.37M |